MetaCap

Tyra Biosciences Insider Trades

NASDAQ: TYRAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

19.94-0.03 (-0.15%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
1 · $20.00K
Sales
14 · $10.59M
Shares bought / sold
971.89 / 552.17K
Net activity
Net selling $10.6 million

Tyra Biosciences insider activity

Over the last 12 months, Tyra Biosciences insiders reported 28 transactions on SEC Form 4: 1 open-market purchase and 14 sales. Insiders bought $20,000 and sold $10.6 million worth of stock, for net insider selling of $10.6 million. The largest seller was MORE ROBERT J, with $5.3 million in reported sales.

The most recent filing shows Fuhrman Alan (Chief Financial Officer) reporting a transaction in 951 shares at $9.13 on Sep 15, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put TYRA's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

TYRA insider transactions

Tyra Biosciences insider transactions
DateInsiderTypeSharesValueFiling
Sep 15, 2026Rueb YuliyaVice President, Finance (PAO)Award2,925$26.70KForm 4
Sep 15, 2026Harris ToddPresident and CEOAward864$7.89KForm 4
Sep 15, 2026Fuhrman AlanChief Financial OfficerAward951$8.68KForm 4
Sep 9, 2026Verjee RehanDirectorBuy972$20.00KForm 4
May 5, 2026Rueb YuliyaVice President, Finance (PAO)Award8,333—Form 4
May 5, 2026Harris ToddPresident and CEOAward79,000—Form 4
May 5, 2026Ashar BhaveshChief Operating OfficerAward15,013—Form 4
May 5, 2026Fuhrman AlanChief Financial OfficerAward20,000—Form 4
May 5, 2026Warner Douglas JChief Medical OfficerAward25,000—Form 4
Mar 26, 2026KAPLAN GILLADirectorDisposition53,172$2.01MForm 4
Mar 26, 2026KAPLAN GILLADirectorOption exercise53,172$119.64KForm 4
Mar 25, 2026KAPLAN GILLADirectorSale14,295$528.51KForm 4
Mar 25, 2026KAPLAN GILLADirectorOption exercise14,295$32.16KForm 4
Mar 13, 2026Fuhrman AlanChief Financial OfficerAward1,376$12.56KForm 4
Mar 13, 2026Harris ToddPresident and CEOAward1,463$13.36KForm 4
Feb 12, 2026Bensen DanielChief Discovery OfficerSale5,872$195.93KForm 4
Feb 12, 2026Bensen DanielChief Discovery OfficerSale2,128$67.04KForm 4
Jan 12, 2026Bensen DanielChief Discovery OfficerSale1,017$29.58KForm 4
Jan 12, 2026Bensen DanielChief Discovery OfficerSale6,983$198.61KForm 4
Dec 19, 2025MORE ROBERT JDirectorSale10,000$250.00KForm 4
Dec 12, 2025Bensen DanielChief Discovery OfficerSale8,000$181.16KForm 4
Nov 21, 2025MORE ROBERT JDirectorSale246,871$5.00MForm 4
Nov 19, 2025Bensen DanielChief Operating OfficerSale49,956$815.30KForm 4
Nov 18, 2025Bensen DanielChief Operating OfficerSale75,633$1.22MForm 4
Nov 17, 2025Bensen DanielChief Operating OfficerSale1,500$25.61KForm 4
Nov 17, 2025Bensen DanielChief Operating OfficerSale18,572$299.19KForm 4
Nov 14, 2025Bensen DanielChief Operating OfficerSale110,228$1.77MForm 4
Nov 13, 2025Bensen DanielChief Operating OfficerSale1,111$17.78KForm 4
Sep 15, 2025Fuhrman AlanChief Financial OfficerAward701$6.40KForm 4
Jun 18, 2025KAPLAN GILLADirectorSale9,568$93.60KForm 4
Jun 17, 2025KAPLAN GILLADirectorSale10$103.50Form 4
Jun 16, 2025KAPLAN GILLADirectorSale6,814$70.73KForm 4
Jun 16, 2025RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund, L.P. & Kolchinsky Peter & Shah Rajeev M.DirectorBuy11,813$119.67KForm 4
Jun 13, 2025KAPLAN GILLADirectorSale15,000$154.58KForm 4
Jun 13, 2025RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund, L.P. & Kolchinsky Peter & Shah Rajeev M.DirectorBuy120,167$1.23MForm 4
Jun 12, 2025KAPLAN GILLADirectorSale30,000$309.25KForm 4
Jun 12, 2025RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund, L.P. & Kolchinsky Peter & Shah Rajeev M.DirectorBuy31,307$319.33KForm 4
Jun 9, 2025RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund, L.P. & Kolchinsky Peter & Shah Rajeev M.DirectorBuy186,850$1.90MForm 4
Jun 5, 2025RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund, L.P. & Kolchinsky Peter & Shah Rajeev M.DirectorBuy213,334$2.14MForm 4
Jun 4, 2025RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund, L.P. & Kolchinsky Peter & Shah Rajeev M.DirectorBuy997,864$9.61MForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related